MedTrace Logo

Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy

NCT07367568 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2026-01-27

No results posted yet for this study

Summary

This study aims to compare the costotransverse foramen block with erector spinae plane block in modified radical mastectomy.

Conditions

  • Costotransverse Foramen Block
  • Erector Spinae Plane Block
  • Modified Radical Mastectomy

Interventions

OTHER

Costotransverse foramen block

Patients will receive an ipsilateral ultrasound-guided costotransverse foramen block with injection of 20 ml bupivacaine 0.25%.

OTHER

Erector spinae plane block

Patients will receive an ipsilateral ultrasound-guided erector spinae plane block with injection of 20 ml bupivacaine 0.25%.

Sponsors & Collaborators

  • National Cancer Institute, Egypt

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-24
Primary Completion
2026-06-01
Completion
2026-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07367568 on ClinicalTrials.gov